ANDA 71068, held by Chartwell RX. Flurazepam Hydrochloride.
As of Nov 21, 2026, ANDA 71068 (Flurazepam Hydrochloride), held by Chartwell RX, was first approved by FDA on Nov 25, 1986, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 25, 1986 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Flurazepam Hydrochloride30MG · capsule;oral | Flurazepam Hydrochloride | Discontinued |
| Jan 17, 2023 | Supplement 18Labeling · Standard review | Approved | None posted |
| Feb 8, 2021 | Supplement 17Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 1, 1993 | Supplement 13Labeling | Approved | None posted |
| Nov 19, 1990 | Supplement 12Manufacturing | Approved | None posted |
| Apr 26, 1989 | Supplement 9Manufacturing | Approved | None posted |
| Apr 26, 1989 | Supplement 8Manufacturing | Approved | None posted |
| Apr 26, 1989 | Supplement 7Manufacturing | Approved | None posted |
| Dec 6, 1988 | Supplement 6Labeling | Approved | None posted |
| Aug 18, 1988 | Supplement 5Labeling | Approved | None posted |
| Jul 30, 1987 | Supplement 2Manufacturing | Approved | None posted |
| Jul 30, 1987 | Supplement 1Manufacturing | Approved | None posted |
| Nov 25, 1986 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters